APEX ARC Hip Implant Failure
Attorneys for APEX ARC Hip Replacement System Lawsuits in New York
Lawsuits have been filed against the hip device manufacturer OMNI Life Sciences, Inc. for failing to warn the public about the potential for early failure and subsequent health issues involved in required revision surgeries.
If you or someone you know has suffered serious health problems and/or required revision surgery after receiving an APEX ARC Hip Replacement System, call our attorneys at (888) 260-0473. We are actively investigating cases involving health issues caused by corrosion and wearing down of the hip implant in a patient’s bloodstream.
Problems with the APEX K2 Hip Implant
OMNI Life Sciences, Inc. distributes and sells this defective hip implant device. Founded in 1999 and headquartered in Massachusetts, Omni Life Services received FDA approval to sell the APEX ARC hip implant in 2004.
The hip device was touted as revolutionary and designed to:
- Treat osteoarthritis, avascular necrosis and other non-inflammatory degenerative joint diseases
- Treat rheumatoid arthritis
- Correct a functional deformity or congenital dislocation
- Revise procedures where other devices may have failed
- Treat fractures of the proximal femur
However, problems soon arose with the hip device. Reports of hip device failures soon after implantation dogged the company. According to Drug Watch, a study published in the Journal of Arthroplasty found and above-average rate of complications in the APEX K2 hip implant, with some wearing down and/or failing within a year of being implanted.
Dr. Michael Kent and colleagues at the Perth Orthopaedic Institute in Australia conducted a study involving 95 patients who received APEX K2 hip stems, the results of which were published in October 2015. In their findings, researchers identified “potentially concerning subsidence (breaking down) of both stems” and “corrosion (wearing down)” of the neck and stem. Corrosion could lead to the implant breaking and microscopic metal particles entering the bloodstream.
Other issues associated with the defective medical device included pain and severe tissue reactions to higher levels of cobalt and chromium in the blood and tissues, non-malignant growths, milky discharge and swelling around the implant site, and deep infections surrounding the implantation site.
APEX ARC Pulled from Australian Market in 2012
Before Kent and colleagues could complete the study, the trial stopped when Global Orthopaedic Technology—a company that partnered with OMNI to distribute the devices in Australia—voluntarily withdrew the implants from the market in 2012 due to above-average revision surgery rates.
According to data gathered by the Australian Orthopaedic Association National Joint Replacement Registry (NJRR) from 2006 to 2012:
- The Apex K2 Modular Hip Replacement System had a revision surgery rate of 5.5% at one year.
- The Apex K2 Modular Hip Replacement System had a revision surgery rate of 9.3 % at three years.
This data means that about 6 in 100 patients could need a second surgery to replace the implant within a year.
We Want to Help You File a Lawsuit Against the Manufacturer
If you’ve experienced complications that required revision surgery after an APEX ARC hip implant failure, we are here to help file a lawsuit against the manufacturer to cover the financial and emotional burdens you’ve endured.
Contact our New York APEX ARC hip implant attorneys onlineor by dialing (888) 260-0473. Consultations are free and confidential.